CONMED Corp — Director's Dealing 2024

Jun 5, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2024-05-31

Reporting Person: Workman John L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-31	Common Stock	M	302	—	Acquired	20412	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-31	Rsus (restricted Stock Units)	$0	M	302	Disposed	2033-06-01	Common Stock (302)	Direct
2024-06-03	Options To Purchase Common Stock	$77.18	A	5503	Acquired	2034-06-03	Common Stock (5503)	Direct
2024-06-03	Rsus (restricted Stock Units)	$0	A	479	Acquired	2034-06-03	Common Stock (479)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.

F2: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.